The global Nitinol Venous Stent System market is projected to grow from US$ 818 million in 2024 to US$ 1305 million by 2031, at a CAGR of 7.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Nitinol Venous Stent System Market

The Nickel-Titanium (NiTi) Venous Stent System is a medical device used for treating venous stenosis or occlusion. The system is made from nickel-titanium alloy (NiTi), known for its superelasticity and shape memory properties. The stent is implanted into a patient's vein through minimally invasive surgery to keep the vessel open, improve blood flow, and prevent thrombosis.

From a downstream perspective, May-Thurner Syndrome accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Nitinol Venous Stent System leading manufacturers including Shanghai Lanmai Medical Technology, Hangzhou Weiqiang Medical Technology, Suzhou Yinluo Medical Devices, Zylox-Tonbridge Medical Technology, Shanghai Ensheng Medical Technology, Suzhou Tianhong Shengjie Medical Devices, BD(Angiomed), Boston Scientific, Cook Ireland, Medtronic, etc., dominate supply; the top five capture approximately % of global revenue, with Shanghai Lanmai Medical Technology leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Nitinol Venous Stent System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Nitinol Venous Stent System Market Report

Report Metric	Details
Report Name	Nitinol Venous Stent System Market
Accounted market size in 2024	US$ 818 million
Forecasted market size in 2031	US$ 1305 million
CAGR	7.0%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Bare Stent Drug-eluting Stent
Segment by Application	May-Thurner Syndrome Post-Thrombotic Syndrome Other
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Shanghai Lanmai Medical Technology, Hangzhou Weiqiang Medical Technology, Suzhou Yinluo Medical Devices, Zylox-Tonbridge Medical Technology, Shanghai Ensheng Medical Technology, Suzhou Tianhong Shengjie Medical Devices, BD(Angiomed), Boston Scientific, Cook Ireland, Medtronic, optimed Medizinische Instrumente, Philips
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Nitinol Venous Stent System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Nitinol Venous Stent System Market growing?

Ans: The Nitinol Venous Stent System Market witnessing a CAGR of 7.0% during the forecast period 2025-2031.

What is the Nitinol Venous Stent System Market size in 2031?

Ans: The Nitinol Venous Stent System Market size in 2031 will be US$ 1305 million.

Who are the main players in the Nitinol Venous Stent System Market report?

Ans: The main players in the Nitinol Venous Stent System Market are Shanghai Lanmai Medical Technology, Hangzhou Weiqiang Medical Technology, Suzhou Yinluo Medical Devices, Zylox-Tonbridge Medical Technology, Shanghai Ensheng Medical Technology, Suzhou Tianhong Shengjie Medical Devices, BD(Angiomed), Boston Scientific, Cook Ireland, Medtronic, optimed Medizinische Instrumente, Philips

What are the Application segmentation covered in the Nitinol Venous Stent System Market report?

Ans: The Applications covered in the Nitinol Venous Stent System Market report are May-Thurner Syndrome, Post-Thrombotic Syndrome, Other

What are the Type segmentation covered in the Nitinol Venous Stent System Market report?

Ans: The Types covered in the Nitinol Venous Stent System Market report are Bare Stent, Drug-eluting Stent

1 Study Coverage

1.1 Introduction to Nitinol Venous Stent System: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Nitinol Venous Stent System Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Bare Stent

1.2.3 Drug-eluting Stent

1.3 Market Segmentation by Application

1.3.1 Global Nitinol Venous Stent System Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 May-Thurner Syndrome

1.3.3 Post-Thrombotic Syndrome

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Nitinol Venous Stent System Revenue Estimates and Forecasts 2020-2031

2.2 Global Nitinol Venous Stent System Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Nitinol Venous Stent System Sales Estimates and Forecasts 2020-2031

2.4 Global Nitinol Venous Stent System Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Nitinol Venous Stent System Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Nitinol Venous Stent System Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Bare Stent Market Size by Manufacturers

3.5.2 Drug-eluting Stent Market Size by Manufacturers

3.6 Global Nitinol Venous Stent System Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Nitinol Venous Stent System Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Nitinol Venous Stent System Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Nitinol Venous Stent System Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Nitinol Venous Stent System Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Nitinol Venous Stent System Sales and Revenue by Type (2020-2031)

6.4 North America Nitinol Venous Stent System Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Nitinol Venous Stent System Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Nitinol Venous Stent System Sales and Revenue by Type (2020-2031)

7.4 Europe Nitinol Venous Stent System Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Nitinol Venous Stent System Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Nitinol Venous Stent System Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Nitinol Venous Stent System Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Nitinol Venous Stent System Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Nitinol Venous Stent System Sales and Revenue by Type (2020-2031)

9.4 Central and South America Nitinol Venous Stent System Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Nitinol Venous Stent System Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Nitinol Venous Stent System Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Nitinol Venous Stent System Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Nitinol Venous Stent System Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Shanghai Lanmai Medical Technology

11.1.1 Shanghai Lanmai Medical Technology Corporation Information

11.1.2 Shanghai Lanmai Medical Technology Business Overview

11.1.3 Shanghai Lanmai Medical Technology Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.1.4 Shanghai Lanmai Medical Technology Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Shanghai Lanmai Medical Technology Nitinol Venous Stent System Sales by Product in 2024

11.1.6 Shanghai Lanmai Medical Technology Nitinol Venous Stent System Sales by Application in 2024

11.1.7 Shanghai Lanmai Medical Technology Nitinol Venous Stent System Sales by Geographic Area in 2024

11.1.8 Shanghai Lanmai Medical Technology Nitinol Venous Stent System SWOT Analysis

11.1.9 Shanghai Lanmai Medical Technology Recent Developments

11.2 Hangzhou Weiqiang Medical Technology

11.2.1 Hangzhou Weiqiang Medical Technology Corporation Information

11.2.2 Hangzhou Weiqiang Medical Technology Business Overview

11.2.3 Hangzhou Weiqiang Medical Technology Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.2.4 Hangzhou Weiqiang Medical Technology Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Hangzhou Weiqiang Medical Technology Nitinol Venous Stent System Sales by Product in 2024

11.2.6 Hangzhou Weiqiang Medical Technology Nitinol Venous Stent System Sales by Application in 2024

11.2.7 Hangzhou Weiqiang Medical Technology Nitinol Venous Stent System Sales by Geographic Area in 2024

11.2.8 Hangzhou Weiqiang Medical Technology Nitinol Venous Stent System SWOT Analysis

11.2.9 Hangzhou Weiqiang Medical Technology Recent Developments

11.3 Suzhou Yinluo Medical Devices

11.3.1 Suzhou Yinluo Medical Devices Corporation Information

11.3.2 Suzhou Yinluo Medical Devices Business Overview

11.3.3 Suzhou Yinluo Medical Devices Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.3.4 Suzhou Yinluo Medical Devices Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Suzhou Yinluo Medical Devices Nitinol Venous Stent System Sales by Product in 2024

11.3.6 Suzhou Yinluo Medical Devices Nitinol Venous Stent System Sales by Application in 2024

11.3.7 Suzhou Yinluo Medical Devices Nitinol Venous Stent System Sales by Geographic Area in 2024

11.3.8 Suzhou Yinluo Medical Devices Nitinol Venous Stent System SWOT Analysis

11.3.9 Suzhou Yinluo Medical Devices Recent Developments

11.4 Zylox-Tonbridge Medical Technology

11.4.1 Zylox-Tonbridge Medical Technology Corporation Information

11.4.2 Zylox-Tonbridge Medical Technology Business Overview

11.4.3 Zylox-Tonbridge Medical Technology Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.4.4 Zylox-Tonbridge Medical Technology Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Zylox-Tonbridge Medical Technology Nitinol Venous Stent System Sales by Product in 2024

11.4.6 Zylox-Tonbridge Medical Technology Nitinol Venous Stent System Sales by Application in 2024

11.4.7 Zylox-Tonbridge Medical Technology Nitinol Venous Stent System Sales by Geographic Area in 2024

11.4.8 Zylox-Tonbridge Medical Technology Nitinol Venous Stent System SWOT Analysis

11.4.9 Zylox-Tonbridge Medical Technology Recent Developments

11.5 Shanghai Ensheng Medical Technology

11.5.1 Shanghai Ensheng Medical Technology Corporation Information

11.5.2 Shanghai Ensheng Medical Technology Business Overview

11.5.3 Shanghai Ensheng Medical Technology Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.5.4 Shanghai Ensheng Medical Technology Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Shanghai Ensheng Medical Technology Nitinol Venous Stent System Sales by Product in 2024

11.5.6 Shanghai Ensheng Medical Technology Nitinol Venous Stent System Sales by Application in 2024

11.5.7 Shanghai Ensheng Medical Technology Nitinol Venous Stent System Sales by Geographic Area in 2024

11.5.8 Shanghai Ensheng Medical Technology Nitinol Venous Stent System SWOT Analysis

11.5.9 Shanghai Ensheng Medical Technology Recent Developments

11.6 Suzhou Tianhong Shengjie Medical Devices

11.6.1 Suzhou Tianhong Shengjie Medical Devices Corporation Information

11.6.2 Suzhou Tianhong Shengjie Medical Devices Business Overview

11.6.3 Suzhou Tianhong Shengjie Medical Devices Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.6.4 Suzhou Tianhong Shengjie Medical Devices Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Suzhou Tianhong Shengjie Medical Devices Recent Developments

11.7 BD(Angiomed)

11.7.1 BD(Angiomed) Corporation Information

11.7.2 BD(Angiomed) Business Overview

11.7.3 BD(Angiomed) Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.7.4 BD(Angiomed) Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 BD(Angiomed) Recent Developments

11.8 Boston Scientific

11.8.1 Boston Scientific Corporation Information

11.8.2 Boston Scientific Business Overview

11.8.3 Boston Scientific Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.8.4 Boston Scientific Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Boston Scientific Recent Developments

11.9 Cook Ireland

11.9.1 Cook Ireland Corporation Information

11.9.2 Cook Ireland Business Overview

11.9.3 Cook Ireland Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.9.4 Cook Ireland Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Cook Ireland Recent Developments

11.10 Medtronic

11.10.1 Medtronic Corporation Information

11.10.2 Medtronic Business Overview

11.10.3 Medtronic Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.10.4 Medtronic Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Medtronic Recent Developments

11.11 optimed Medizinische Instrumente

11.11.1 optimed Medizinische Instrumente Corporation Information

11.11.2 optimed Medizinische Instrumente Business Overview

11.11.3 optimed Medizinische Instrumente Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.11.4 optimed Medizinische Instrumente Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 optimed Medizinische Instrumente Recent Developments

11.12 Philips

11.12.1 Philips Corporation Information

11.12.2 Philips Business Overview

11.12.3 Philips Nitinol Venous Stent System Product Models, Descriptions and Specifications

11.12.4 Philips Nitinol Venous Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Philips Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Nitinol Venous Stent System Industry Chain

12.2 Nitinol Venous Stent System Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Nitinol Venous Stent System Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Nitinol Venous Stent System Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Nitinol Venous Stent System Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Nitinol Venous Stent System Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Suzhou Yinluo Medical Devices

Zylox-Tonbridge Medical Technology

Boston Scientific

Medtronic Inc

OptiMed Medizinische Instrumente

Philips

Shanghai Lanmai Medical Technology

Hangzhou Weiqiang Medical Technology

Shanghai Ensheng Medical Technology

Suzhou Tianhong Shengjie Medical Devices

BD(Angiomed)

Cook Ireland

List of Tables

Table 1. Global Nitinol Venous Stent System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Nitinol Venous Stent System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Nitinol Venous Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Nitinol Venous Stent System Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Nitinol Venous Stent System Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Nitinol Venous Stent System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Nitinol Venous Stent System Sales by Region (2020-2025) & (K Units)

Table 8. Global Nitinol Venous Stent System Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Nitinol Venous Stent System Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Nitinol Venous Stent System Sales Share by Manufacturers (2020-2025)

Table 12. Global Nitinol Venous Stent System Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Nitinol Venous Stent System Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Nitinol Venous Stent System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitinol Venous Stent System as of 2024)

Table 16. Global Nitinol Venous Stent System Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Nitinol Venous Stent System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Nitinol Venous Stent System Manufacturing Base and Headquarters

Table 19. Global Nitinol Venous Stent System Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Nitinol Venous Stent System Sales by Type (2020-2025) & (K Units)

Table 23. Global Nitinol Venous Stent System Sales by Type (2026-2031) & (K Units)

Table 24. Global Nitinol Venous Stent System Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Nitinol Venous Stent System Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Nitinol Venous Stent System ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Nitinol Venous Stent System Sales by Application (2020-2025) & (K Units)

Table 29. Global Nitinol Venous Stent System Sales by Application (2026-2031) & (K Units)

Table 30. Nitinol Venous Stent System High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Nitinol Venous Stent System Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Nitinol Venous Stent System Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Nitinol Venous Stent System ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Nitinol Venous Stent System Growth Accelerators and Market Barriers

Table 37. North America Nitinol Venous Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Nitinol Venous Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Nitinol Venous Stent System Growth Accelerators and Market Barriers

Table 40. Europe Nitinol Venous Stent System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Nitinol Venous Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Nitinol Venous Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Nitinol Venous Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Nitinol Venous Stent System Growth Accelerators and Market Barriers

Table 45. Southeast Asia Nitinol Venous Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Nitinol Venous Stent System Investment Opportunities and Key Challenges

Table 47. Central and South America Nitinol Venous Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Nitinol Venous Stent System Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Nitinol Venous Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Shanghai Lanmai Medical Technology Corporation Information

Table 51. Shanghai Lanmai Medical Technology Description and Major Businesses

Table 52. Shanghai Lanmai Medical Technology Product Models, Descriptions and Specifications

Table 53. Shanghai Lanmai Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Shanghai Lanmai Medical Technology Sales Value Proportion by Product in 2024

Table 55. Shanghai Lanmai Medical Technology Sales Value Proportion by Application in 2024

Table 56. Shanghai Lanmai Medical Technology Sales Value Proportion by Geographic Area in 2024

Table 57. Shanghai Lanmai Medical Technology Nitinol Venous Stent System SWOT Analysis

Table 58. Shanghai Lanmai Medical Technology Recent Developments

Table 59. Hangzhou Weiqiang Medical Technology Corporation Information

Table 60. Hangzhou Weiqiang Medical Technology Description and Major Businesses

Table 61. Hangzhou Weiqiang Medical Technology Product Models, Descriptions and Specifications

Table 62. Hangzhou Weiqiang Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Hangzhou Weiqiang Medical Technology Sales Value Proportion by Product in 2024

Table 64. Hangzhou Weiqiang Medical Technology Sales Value Proportion by Application in 2024

Table 65. Hangzhou Weiqiang Medical Technology Sales Value Proportion by Geographic Area in 2024

Table 66. Hangzhou Weiqiang Medical Technology Nitinol Venous Stent System SWOT Analysis

Table 67. Hangzhou Weiqiang Medical Technology Recent Developments

Table 68. Suzhou Yinluo Medical Devices Corporation Information

Table 69. Suzhou Yinluo Medical Devices Description and Major Businesses

Table 70. Suzhou Yinluo Medical Devices Product Models, Descriptions and Specifications

Table 71. Suzhou Yinluo Medical Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Suzhou Yinluo Medical Devices Sales Value Proportion by Product in 2024

Table 73. Suzhou Yinluo Medical Devices Sales Value Proportion by Application in 2024

Table 74. Suzhou Yinluo Medical Devices Sales Value Proportion by Geographic Area in 2024

Table 75. Suzhou Yinluo Medical Devices Nitinol Venous Stent System SWOT Analysis

Table 76. Suzhou Yinluo Medical Devices Recent Developments

Table 77. Zylox-Tonbridge Medical Technology Corporation Information

Table 78. Zylox-Tonbridge Medical Technology Description and Major Businesses

Table 79. Zylox-Tonbridge Medical Technology Product Models, Descriptions and Specifications

Table 80. Zylox-Tonbridge Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Zylox-Tonbridge Medical Technology Sales Value Proportion by Product in 2024

Table 82. Zylox-Tonbridge Medical Technology Sales Value Proportion by Application in 2024

Table 83. Zylox-Tonbridge Medical Technology Sales Value Proportion by Geographic Area in 2024

Table 84. Zylox-Tonbridge Medical Technology Nitinol Venous Stent System SWOT Analysis

Table 85. Zylox-Tonbridge Medical Technology Recent Developments

Table 86. Shanghai Ensheng Medical Technology Corporation Information

Table 87. Shanghai Ensheng Medical Technology Description and Major Businesses

Table 88. Shanghai Ensheng Medical Technology Product Models, Descriptions and Specifications

Table 89. Shanghai Ensheng Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Shanghai Ensheng Medical Technology Sales Value Proportion by Product in 2024

Table 91. Shanghai Ensheng Medical Technology Sales Value Proportion by Application in 2024

Table 92. Shanghai Ensheng Medical Technology Sales Value Proportion by Geographic Area in 2024

Table 93. Shanghai Ensheng Medical Technology Nitinol Venous Stent System SWOT Analysis

Table 94. Shanghai Ensheng Medical Technology Recent Developments

Table 95. Suzhou Tianhong Shengjie Medical Devices Corporation Information

Table 96. Suzhou Tianhong Shengjie Medical Devices Description and Major Businesses

Table 97. Suzhou Tianhong Shengjie Medical Devices Product Models, Descriptions and Specifications

Table 98. Suzhou Tianhong Shengjie Medical Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Suzhou Tianhong Shengjie Medical Devices Recent Developments

Table 100. BD(Angiomed) Corporation Information

Table 101. BD(Angiomed) Description and Major Businesses

Table 102. BD(Angiomed) Product Models, Descriptions and Specifications

Table 103. BD(Angiomed) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. BD(Angiomed) Recent Developments

Table 105. Boston Scientific Corporation Information

Table 106. Boston Scientific Description and Major Businesses

Table 107. Boston Scientific Product Models, Descriptions and Specifications

Table 108. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Boston Scientific Recent Developments

Table 110. Cook Ireland Corporation Information

Table 111. Cook Ireland Description and Major Businesses

Table 112. Cook Ireland Product Models, Descriptions and Specifications

Table 113. Cook Ireland Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Cook Ireland Recent Developments

Table 115. Medtronic Corporation Information

Table 116. Medtronic Description and Major Businesses

Table 117. Medtronic Product Models, Descriptions and Specifications

Table 118. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Medtronic Recent Developments

Table 120. optimed Medizinische Instrumente Corporation Information

Table 121. optimed Medizinische Instrumente Description and Major Businesses

Table 122. optimed Medizinische Instrumente Product Models, Descriptions and Specifications

Table 123. optimed Medizinische Instrumente Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. optimed Medizinische Instrumente Recent Developments

Table 125. Philips Corporation Information

Table 126. Philips Description and Major Businesses

Table 127. Philips Product Models, Descriptions and Specifications

Table 128. Philips Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Philips Recent Developments

Table 130. Key Raw Materials Distribution

Table 131. Raw Materials Key Suppliers

Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 133. Milestones in Production Technology Evolution

Table 134. Distributors List

Table 135. Market Trends and Market Evolution

Table 136. Market Drivers and Opportunities

Table 137. Market Challenges, Risks, and Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Nitinol Venous Stent System Product Picture

Figure 2. Global Nitinol Venous Stent System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Bare Stent Product Picture

Figure 4. Drug-eluting Stent Product Picture

Figure 5. Global Nitinol Venous Stent System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. May-Thurner Syndrome

Figure 7. Post-Thrombotic Syndrome

Figure 8. Other

Figure 9. Nitinol Venous Stent System Report Years Considered

Figure 10. Global Nitinol Venous Stent System Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 12. Global Nitinol Venous Stent System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Nitinol Venous Stent System Revenue Market Share by Region (2020-2031)

Figure 14. Global Nitinol Venous Stent System Sales (2020-2031) & (K Units)

Figure 15. Global Nitinol Venous Stent System Sales (CAGR) by Region (2020-2031) (K Units)

Figure 16. Global Nitinol Venous Stent System Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Nitinol Venous Stent System Sales Volume Market Share in 2024

Figure 18. Global Nitinol Venous Stent System Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Bare Stent Revenue Market Share by Manufacturer in 2024

Figure 21. Drug-eluting Stent Revenue Market Share by Manufacturer in 2024

Figure 22. Global Nitinol Venous Stent System Sales Market Share by Type (2020-2031)

Figure 23. Global Nitinol Venous Stent System Revenue Market Share by Type (2020-2031)

Figure 24. Global Nitinol Venous Stent System Sales Market Share by Application (2020-2031)

Figure 25. Global Nitinol Venous Stent System Revenue Market Share by Application (2020-2031)

Figure 26. North America Nitinol Venous Stent System Sales YoY (2020-2031) & (K Units)

Figure 27. North America Nitinol Venous Stent System Revenue YoY (2020-2031) & (US$ Million)

Figure 28. North America Top 5 Manufacturers Nitinol Venous Stent System Sales Revenue (US$ Million) in 2024

Figure 29. North America Nitinol Venous Stent System Sales Volume (K Units) by Type (2020- 2031)

Figure 30. North America Nitinol Venous Stent System Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 31. North America Nitinol Venous Stent System Sales Volume (K Units) by Application (2020-2031)

Figure 32. North America Nitinol Venous Stent System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 33. US Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 34. Canada Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 35. Mexico Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 36. Europe Nitinol Venous Stent System Sales YoY (2020-2031) & (K Units)

Figure 37. Europe Nitinol Venous Stent System Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Europe Top 5 Manufacturers Nitinol Venous Stent System Sales Revenue (US$ Million) in 2024

Figure 39. Europe Nitinol Venous Stent System Sales Volume (K Units) by Type (2020-2031)

Figure 40. Europe Nitinol Venous Stent System Sales Revenue (US$ Million) by Type (2020-2031)

Figure 41. Europe Nitinol Venous Stent System Sales Volume (K Units) by Application (2020-2031)

Figure 42. Europe Nitinol Venous Stent System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. Germany Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 44. France Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 45. U.K. Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 46. Italy Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 47. Russia Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 48. Asia-Pacific Nitinol Venous Stent System Sales YoY (2020-2031) & (K Units)

Figure 49. Asia-Pacific Nitinol Venous Stent System Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Top 8 Manufacturers Nitinol Venous Stent System Sales Revenue (US$ Million) in 2024

Figure 51. Asia-Pacific Nitinol Venous Stent System Sales Volume (K Units) by Type (2020- 2031)

Figure 52. Asia-Pacific Nitinol Venous Stent System Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 53. Asia-Pacific Nitinol Venous Stent System Sales Volume (K Units) by Application (2020-2031)

Figure 54. Asia-Pacific Nitinol Venous Stent System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Indonesia Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 56. Japan Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 57. South Korea Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 58. China Taiwan Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 59. India Nitinol Venous Stent System Revenue (2020-2031) & (US$ Million)

Figure 60. Central and South America Nitinol Venous Stent System Sales YoY (2020-2031) & (K Units)

Figure 61. Central and South America Nitinol Venous Stent System Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Central and South America Top 5 Manufacturers Nitinol Venous Stent System Sales Revenue (US$ Million) in 2024

Figure 63. Central and South America Nitinol Venous Stent System Sales Volume (K Units) by Type (2021-2031)

Figure 64. Central and South America Nitinol Venous Stent System Sales Revenue (US$ Million) by Type (2020-2031)

Figure 65. Central and South America Nitinol Venous Stent System Sales Volume (K Units) by Application (2020-2031)

Figure 66. Central and South America Nitinol Venous Stent System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Brazil Nitinol Venous Stent System Revenue (2020-2025) & (US$ Million)

Figure 68. Argentina Nitinol Venous Stent System Revenue (2020-2025) & (US$ Million)

Figure 69. Middle East, and Africa Nitinol Venous Stent System Sales YoY (2020-2031) & (K Units)

Figure 70. Middle East and Africa Nitinol Venous Stent System Revenue YoY (2020-2031) & (US$ Million)

Figure 71. Middle East and Africa Top 5 Manufacturers Nitinol Venous Stent System Sales Revenue (US$ Million) in 2024

Figure 72. Middle East and Africa Nitinol Venous Stent System Sales Volume (K Units) by Type (2021-2031)

Figure 73. South America Nitinol Venous Stent System Sales Revenue (US$ Million) by Type (2020-2031)

Figure 74. Middle East and Africa Nitinol Venous Stent System Sales Volume (K Units) by Application (2020-2031)

Figure 75. Middle East and Africa Nitinol Venous Stent System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 76. GCC Countries Nitinol Venous Stent System Revenue (2020-2025) & (US$ Million)

Figure 77. Turkey Nitinol Venous Stent System Revenue (2020-2025) & (US$ Million)

Figure 78. Egypt Nitinol Venous Stent System Revenue (2020-2025) & (US$ Million)

Figure 79. South Africa Nitinol Venous Stent System Revenue (2020-2025) & (US$ Million)

Figure 80. Nitinol Venous Stent System Industry Chain Mapping

Figure 81. Regional Nitinol Venous Stent System Manufacturing Base Distribution (%)

Figure 82. Global Nitinol Venous Stent System Production Market Share by Region (2020-2031)

Figure 83. Nitinol Venous Stent System Production Process

Figure 84. Regional Nitinol Venous Stent System Production Cost Structure

Figure 85. Channels of Distribution (Direct Vs Distribution)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions